Skip to main content

Autoinjectors Market | Newest Industry Data, Future Trends and Forecast 2023

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs.

The global autoinjectors market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023).

In terms of Therapy, the global autoinjectors market can be segmented into:

  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Other Therapies (Cardiovascular Diseases, Migraines, Psoriasis, and Anemia)

By therapy, the rheumatoid arthritis segment is expected to account for the largest share of the market in 2018

On the basis of therapy, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies such as migraines, cardiovascular diseases, psoriasis, and anemia. In 2018, the rheumatoid arthritis segment is expected to account for the largest share of the global market. The large share of this segment can be primarily attributed to the high prevalence of rheumatoid arthritis across the globe.

Get a sample PDF copy of the Report @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724


Browse and in-depth TOC on "Autoinjectors Market"
66 - Tables
36 - Figures
133 - Pages

The geographical regions mapped in the report are:

  • North America
  • Europe
  • APAC
  • Rest of the World

North America to dominate the market in 2018
In 2018, North America is expected to account for the largest share of the autoinjectors market, followed by Europe. Factors such as increasing geriatric population in Canada, increasing FDA approvals, rising prevalence of anaphylaxis in the US, and rising prevalence of autoimmune and chronic diseases in the US and Canada are contributing to the large share of North America.

Some key players mentioned in the research report are:

The key players in the global autoinjectors market are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US). The other prominent players in the market are J&J (US), Novartis (Switzerland), Bayer (Germany), Merck (Germany), Biogen (US), Ypsomed (Switzerland), SHL Group (Taiwan) Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), and Haselmeier (Switzerland).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Potential Impact Of COVID-19 On Walking Assist Devices Market

The global market is expected to witness growth in the coming years, owing to factors such as the increase in the number of initiatives undertaken by governments of various countries to ensure availability of walking assist devices to a huge consumer base, rise in aging population, and increasing incidences of Debilitating Neurological Diseases & Injuries. The  global walking assist devices market  is expected to reach $6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020. Walking Assist Devices Market by Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), and Region (North America, Europe, Asia-Pacific and ROW) – Global Forecast to 2020 Download PDF Brochure :  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=98811670 Global Walking Assist Devices Market is Segmented on: 1. Product Type 2. Geography Product Type Based on product, the global market is classified into gaits belts and lift vests, canes, crutches,...
Post a Comment
Read more

Vaccine Adjuvants Market Analysis as per the Latest COVID-19 Impact

The global  vaccine adjuvants market  consists of human and veterinary adjuvants that are used to improve the efficacy of vaccines. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on the prevention of diseases. The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%. What Drives the Market? 1. Increasing Use of Adjuvants in Vaccine 2. High Prevalence of Infectious and Zoonotic Diseases 3. Increase in Livestock and Instances of Diseases 4. Increasing Focus on Immunization Programs From Various Government Bodies 5. Technological Advancements in Aluminum Hydroxide-Based Adjuvants The research applications segment is expected to account for the largest share of the market during the forecast period. The human vaccine adjuvants segment is expected to account...
Post a Comment
Read more

Ambulatory Surgical Centers Market To Reach USD 7.2 Billion By 2025 – Increasing Investment In Supply Chain Management

  What This Report Will Provide? The study involved four major activities in estimating the size of the Ambulatory Surgical Centers market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their regional adoption trends. Industry experts further validated the data obtained through secondary research through primary research. Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level data for outpatient surgical procedures) and top-down approach (assessment of utilization/adoption/penetration trends, by product and services, components, and specialty type). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments. Expected Revenue Growth : [176 Pages Report] The  Ambulatory surgical centers market  is projected to reach USD 7.2 billion by 2025 from 2.1 billion in 20...
Post a Comment
Read more